Oleoylethanolamide-based Treatment in Obesity: A Retrospective Analysis of 100 Cases from a Single Center in the Northern Territory of India
Abstract: Background & Objectives: New therapeutic approaches with minimal or no adverse effects are needed to contain and counter the epidemic of obesity. Oleoylethanolamide is a bioactive lipid mediator shown to cause satiety, weight loss, and lipolysis in clinical studies. This retrospective analysis investigated the characteristics of patients initiated on the combination of oleoylethanolamide (200 mg), pantethine (75 mg) and valine (10 mg) treatment in routine clinical care and further assessed subsequent changes in weight, glycaemic and metabolic profile. Method: The analysis reviewed electronic records of 100 obese patients treated with the above combination between July 15, 2018 and December 15, 2018. Results: At the end of 3 months, daily intake of the above combination reduced the mean weight (6.16 kg), waist circumference (4.77 cm), total body fat (3.14 %) and BMI (1.99 kg/m2), significantly (p
Keywords: Obesity, Oleoylethanolamide, Pantethine, Valine, Appetite suppression
How to Cite?: Abhyudaya Verma, Deepika Verma, Pooja Bansal, Akhil Bansal, "Oleoylethanolamide-based Treatment in Obesity: A Retrospective Analysis of 100 Cases from a Single Center in the Northern Territory of India", Volume 8 Issue 7, July 2019, International Journal of Science and Research (IJSR), Pages: 502-507, https://www.ijsr.net/getabstract.php?paperid=ART20199227, DOI: https://dx.doi.org/10.21275/ART20199227